AgomAb Therapeutics NV American Depositary Shares (AGMB) — Long-term Investment Intensity
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Long-term Investment Intensity of 0.0% as of December 2025. Long-term investments of $11.00K represent 0.0% of total assets of $153.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of AgomAb Therapeutics NV American Deposita for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AgomAb Therapeutics NV American Depositary Shares Long-term Investment Intensity (2021–2025)
This chart shows how AgomAb Therapeutics NV American Depositary Shares's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 0.0%, reflecting long-term investments of $11.00K against total assets of $153.71 Million USD. Also explore AGMB current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for AgomAb Therapeutics NV American Depositary Shares (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of AgomAb Therapeutics NV American Deposita.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.0% | $11.00K | $153.71 Million | ▲ +0.0 pp |
| 2024 | 0.0% | $12.00K | $206.36 Million | ▼ 0.0 pp |
| 2023 | 0.0% | $14.00K | $171.26 Million | ▼ 0.0 pp |
| 2022 | 0.0% | $14.00K | $101.00 Million | ▼ -0.2 pp |
| 2021 | 0.2% | $147.00K | $84.00 Million | — |